S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Laser breakthrough could send stock soaring 2,467% (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Laser breakthrough could send stock soaring 2,467% (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Laser breakthrough could send stock soaring 2,467% (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds a major oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Laser breakthrough could send stock soaring 2,467% (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Laser breakthrough could send stock soaring 2,467% (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Laser breakthrough could send stock soaring 2,467% (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds a major oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Laser breakthrough could send stock soaring 2,467% (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Laser breakthrough could send stock soaring 2,467% (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Laser breakthrough could send stock soaring 2,467% (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds a major oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Laser breakthrough could send stock soaring 2,467% (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Laser breakthrough could send stock soaring 2,467% (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Laser breakthrough could send stock soaring 2,467% (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds a major oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
NASDAQ:AIMT

Aimmune Therapeutics (AIMT) Earnings Date, Estimates & Call Transcripts

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$34.49
$34.49
50-Day Range
$34.30
$34.59
52-Week Range
$10.09
$37.00
Volume
N/A
Average Volume
1.71 million shs
Market Capitalization
$2.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Aimmune Therapeutics Analyst Forecasts

Current Year EPS Consensus Estimate:($4.35) EPS
Next Year EPS Consensus Estimate: ($2.93) EPS

Aimmune Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript












Aimmune Therapeutics Earnings - Frequently Asked Questions

How much profit does Aimmune Therapeutics generate each year?

Aimmune Therapeutics (NASDAQ:AIMT) has a recorded net income of -$248.50 million. AIMT has generated -$3.97 earnings per share over the last four quarters.

What is Aimmune Therapeutics's EPS forecast for next year?

Aimmune Therapeutics's earnings are expected to grow from ($4.35) per share to ($2.93) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:AIMT) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -